PLATANIA, CHIARA BIANCA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.005
EU - Europa 1.072
AS - Asia 738
AF - Africa 211
SA - Sud America 183
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 4.216
Nazione #
US - Stati Uniti d'America 1.946
IT - Italia 531
SG - Singapore 411
CN - Cina 223
IE - Irlanda 206
BR - Brasile 165
CI - Costa d'Avorio 117
UA - Ucraina 86
DE - Germania 73
SN - Senegal 71
CA - Canada 41
RU - Federazione Russa 40
GB - Regno Unito 32
KR - Corea 23
SE - Svezia 23
IN - India 21
FI - Finlandia 15
MX - Messico 13
VN - Vietnam 13
FR - Francia 12
NL - Olanda 9
BE - Belgio 8
NG - Nigeria 8
PL - Polonia 8
BD - Bangladesh 7
ES - Italia 6
AT - Austria 5
CH - Svizzera 5
JP - Giappone 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
EU - Europa 4
IQ - Iraq 4
KE - Kenya 4
MA - Marocco 4
TR - Turchia 4
ZA - Sudafrica 4
AU - Australia 3
CO - Colombia 3
GR - Grecia 3
HK - Hong Kong 3
NP - Nepal 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
JO - Giordania 2
KG - Kirghizistan 2
TN - Tunisia 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GT - Guatemala 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
Totale 4.216
Città #
Santa Clara 435
Chandler 325
Singapore 257
Dublin 206
Catania 181
Chicago 159
Abidjan 117
Jacksonville 94
Houston 86
Boardman 83
Dakar 71
Cambridge 49
Lawrence 48
Ashburn 47
Andover 44
Hefei 39
Civitanova Marche 36
Toronto 27
Wilmington 27
Des Moines 25
Nanjing 23
Bremen 22
Seoul 20
Rome 19
The Dalles 18
Falls Church 16
Messina 16
Columbus 15
Seattle 15
Council Bluffs 14
Palermo 14
Aci Catena 13
Milan 13
Munich 12
Redwood City 11
São Paulo 11
Beijing 10
Boydton 10
Changsha 10
Dong Ket 10
Hebei 10
Los Angeles 10
Ottawa 10
Saint Petersburg 10
Shenyang 10
Rio de Janeiro 9
San Mateo 9
Abuja 8
Grafing 8
Mumbai 8
Redmond 8
Belo Horizonte 7
Jiaxing 7
Nanchang 7
Naples 7
Rosolini 7
San Gregorio di Catania 7
Warsaw 7
Dearborn 6
Guangzhou 6
Mercogliano 6
Pozzallo 6
Shanghai 6
Brooklyn 5
Brussels 5
Hyderabad 5
Manaus 5
Manchester 5
Moscow 5
Turku 5
Washington 5
Baranzate 4
Brasília 4
Cagliari 4
Helsinki 4
Jinan 4
Lappeenranta 4
London 4
Mexico City 4
Nairobi 4
New York 4
Ningbo 4
Novara 4
Phoenix 4
Pune 4
Stockholm 4
Sumaré 4
Tianjin 4
Tokyo 4
Turin 4
Vicenza 4
Zhengzhou 4
Boston 3
Caltanissetta 3
Casaleone 3
Curitiba 3
Enna 3
Garza García 3
Kathmandu 3
Lecce 3
Totale 2.975
Nome #
Current drug treatments targeting dopamine D3 receptor 172
Antioxidant and osmoprotecting activity of taurine in dry eye models 118
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 106
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 102
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 101
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 101
Caffeine Protects Against Retinal Inflammation 96
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 95
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 94
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 93
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 92
P2X7 receptor antagonism: implications in diabetic retinopathy 88
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 83
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 81
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 80
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 80
Controversies in Glaucoma: Current Medical Treatment and Drug Development 76
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 76
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 76
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 74
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 73
Retinal protection and distribution of curcumin in vitro and in vivo 73
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 73
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 72
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 71
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 69
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 69
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 68
Novel therapeutics in glaucoma management 67
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 67
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 65
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 65
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 65
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 64
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 64
Ocular allergy 63
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 63
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 61
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 60
Ocular pharmacological profile of hydrocortisone in dry eye disease 60
Do extracellular RNAs provide insight into uveal melanoma biology? 59
MicroRNA target prediction in glaucoma 58
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 57
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 56
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 56
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 56
Novel heme oxygenase-1 (Ho-1) inducers based on dimethyl fumarate structure 55
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 55
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 53
Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose 51
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors 50
In-Silico Characterization of von Willebrand Factor Bound to FVIII 47
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 45
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease 44
Integrating network pharmacology: The next-generation approach in ocular drug discovery 41
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 40
Characterization of protein-protein interfaces through a protein contact network approach 39
The P2X7 receptor as a new pharmacological target for retinal diseases 38
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs 35
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. 35
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 31
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study 31
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies 28
Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) 21
Ocular Allergies 17
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells 13
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 11
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach 10
Totale 4.348
Categoria #
all - tutte 16.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 15 16 21 3 53 13 34 5 19 15 27 20
2021/2022403 31 45 10 8 52 25 66 23 32 6 19 86
2022/2023939 62 66 18 110 123 122 16 172 176 16 31 27
2023/2024409 32 45 18 21 31 116 7 31 1 3 57 47
2024/20251.821 43 259 84 129 379 246 106 57 134 108 160 116
2025/202682 82 0 0 0 0 0 0 0 0 0 0 0
Totale 4.348